Signos Raises $20M for Its FDA-Cleared CGM-Based Weight Management System

Signos Raises $20M for Its FDA-Cleared CGM-Based Weight Management System Signos, the company behind the first FDA-cleared over-the-counter glucose monitoring system for weight management, has raised $20 million from GV (Google Ventures), Dexcom, and Blue Cross Blue Shield of Alabama. As part of the partnership, Signos will be available for purchase on Stelo.com, Dexcom’s direct-to-consumer CGM site. Read More from the Global Wellness News ™

Factory Capital Commits $18M to Build Women’s Midlife Health Into an Institutional Investment Category

Factory Capital Commits $18M to Build Women’s Midlife Health Into an Institutional Investment Category Sydney-based Factory Capital has committed A$25 million (approximately $18 million) to build women’s midlife health into an institutional investment category – starting not with startup investments but with clinical infrastructure. Read More from the Global Wellness News ™